Cardiovascular Systems Inc FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Dec 14, 2022
  • 3 Class I recalls
  • No warning letters matched by name
Inspections 9 0 OAI
Recalls 15 3 Class I (20%)
Warning letters 0 None on file
510(k) clearances 28 Latest Mar 1, 2022

Cardiovascular Systems Inc has 15 FDA recalls (3 Class I), 9 inspections, 28 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Cardiovascular Systems Inc" is on file.

What these totals cover: FDA records filed under the name "Cardiovascular Systems Inc" and its spelling variants "Cardiovascular Systems", "Cardiovascular Systems Incorporated". They do not include records filed under Abbott Laboratories or other names in its corporate family; those are listed under Related names, each with its own counts.

Latest recall
Z-0961-2026 · Nov 13, 2025 · filed under Abbott Laboratories
Latest recall under this name
Z-0394-2022 · Class I · Nov 22, 2021
Latest inspection
Dec 14, 2022 · NAI
Latest 510(k)
Mar 1, 2022

Newer recall under related name Abbott Laboratories: Nov 13, 2025, Z-0961-2026.

Part of the Abbott Laboratories corporate family.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls15 (3 Class I)Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances28Nov 15, 2026File dated Nov 9, 2026Current
Inspections9Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Cardiovascular Systems Inc's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Cardiovascular Systems Inc: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 5 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 3 recall records (1 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300000
202210000
202100031
202000000
201900000
201800010
201700050

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Cardiovascular Systems Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Cardiovascular Systems Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

15 recall records from Jun 18, 2012 to Nov 22, 2021.

NumberClassProductDate
Z-0394-2022Class IWIRION EMBOLIC PROTECTION SYSTEM, Delivery Catheter and Filter and Retrieval Catheter, 6Fr, REF…Nov 22, 2021
Z-2386-2021Class IISTEALTH 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM, 1.25MM MICRO, 145 CM, REF PRD-SC30-MICROJul 21, 2021
Z-2385-2021Class IIDIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM, 1.5MM SOLID, 145 CM, REF DBP-150SOLID145Jul 21, 2021
Z-3021-2018Class IICSI, Orbital Atherectomy System (OAS) Saline Infusion Pump, Rx only, Part Number: 7-10014, Model…Apr 13, 2018
Z-0506-2018Class IIPeripheral Diamondback 1.50 Solid OAD, a percutaneous orbital atherectomy system indicated for use…Sep 14, 2017
Z-0505-2018Class IIPeripheral Diamondback 1.25 Solid OAD, a percutaneous orbital atherectomy system indicated for use…Sep 14, 2017
Z-2122-2017Class IICSI, Orbital Atherectomy System (OAS) Saline Infusion Pump, Rx only, Part Number: 7-10014, Model…Apr 14, 2017
Z-1771-2017Class IIViperWire Advance Peripheral Guide Wire with Flex Tip, Model No. VPR-GW-FT18. Sterilized with…Mar 3, 2017
Z-1877-2017Class IIViperWire Advance with Flextip Peripheral Atherectomy Guide Wire, Part Number: 7-10026-01,Model…Feb 9, 2017
Z-1230-2017Class IIDIAMONDBACK 360 Peripheral 1.50 Classic, Model DBP-150CLASS145 Peripheral Orbital Atherectomy…Dec 7, 2016
Z-2051-2016Class IIViperWire Advance Peripheral Guide Wire, Sterilized with Ethylene Oxide, Rx Only. Part number…Jun 13, 2016
Z-1290-2015Class IDiamondback 360 Coronary Orbital Atherectomy System, Model Number: DBEC-125. The system is…Mar 4, 2015
Z-2155-2014Class ICSI Cardiovascular Systems, Inc., Diamondback 360 Peripheral Orbital Atherectomy System, Model…May 23, 2014
Z-1095-2014Class IIICSI, Diamondback 360 Coronary Orbital Atherectomy System, Part Number 70058-02, Model Number…Jan 27, 2014
Z-1959-2012Class IICSI Stealth 360-degree Orbital Atherectomy Device (OAD), Part Number 70056-11, Model Number…Jun 18, 2012

Recent FDA inspections

9 inspections from Aug 5, 2010 to Dec 14, 2022.

DateSiteProductClassificationFEI
Dec 14, 2022Saint Paul, MNDevicesNo Action Indicated (NAI)3004742232
Sep 1, 2016Saint Paul, MNDevicesNo Action Indicated (NAI)3004742232
Jul 12, 2016Pearland, TXDevicesNo Action Indicated (NAI)3008814558
Sep 25, 2015Saint Paul, MNDevicesNo Action Indicated (NAI)3004742232
Dec 12, 2014Pearland, TXDevicesVoluntary Action Indicated (VAI)3008814558
Oct 24, 2014Saint Paul, MNDevicesVoluntary Action Indicated (VAI)3004742232
Dec 19, 2012Saint Paul, MNDevicesNo Action Indicated (NAI)3004742232
Sep 27, 2012Saint Paul, MNDevicesNo Action Indicated (NAI)3004742232
Aug 5, 2010Saint Paul, MNDevicesNo Action Indicated (NAI)3004742232
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

2 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3004742232Saint Paul, MN7Dec 14, 2022
FEI 3008814558Pearland, TX2Jul 12, 2016

Recent 510(k) clearances

28 510(k) clearances from Jan 31, 2005 to Mar 1, 2022. Showing the 20 most recent. View all 28 510(k) clearances

K-NumberDeviceDate
K220109DIAMONDBACK 360 Peripheral Orbital Atherectomy System, DIAMONDBACK 360 Peripheral Orbital…Mar 1, 2022
K212725ViperCross Support CathetersSep 24, 2021
K210586Diamonback 360 Peripheral Orbital Atherectomy System, Diamondback 360 Stealth Orbital Atherectomy…Sep 14, 2021
K211240ViperCross Support CathetersAug 26, 2021
K211251ViperCath XC Peripheral Exchange CatheterMay 26, 2021
K210282WIRION Embolic Protection SystemMar 3, 2021
K203008DIAMONDBACK 360 Peripheral Orbital Atherectomy System, DIAMONDBACK 360 Peripheral Orbital…Nov 19, 2020
K200198WIRIONMar 18, 2020
K190634Diamondback 360 Peripheral Orbital Atherectomy System, Stealth 360 Peripheral Orbital Atherectomy…Jul 2, 2019
K183000ViperCath XC Peripheral Exchange CatheterDec 29, 2018
K182397Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable SeriesDec 13, 2018
K180416ViperWire Advance Guide Wire, Stealth 360 Orbital Peripheral Atherectomy Device (PAD), DIAMONDBACK…Apr 17, 2018
K170792Diamondback 360 Peripheral Orbital Atherectomy SystemJun 9, 2017
K152694Diamondback 360 Peripheral Orbital Atherectomy SystemOct 21, 2015
K150732Diamondback 360 Peripheral Orbital Atherectomy SystemApr 13, 2015
K133999DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEMFeb 28, 2014
K133399DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEMNov 22, 2013
K122987STEALTH 360 ORBITAL PAD SYSTEMOct 25, 2012
K111388DIAMONDBACK 360* ORBITAL ATHERECTOMY SYSTEM, STEALTH 360* ORBITAL PAD SYSTEMJul 26, 2011
K110389STEALTH 360 ORBITAL PAD SYSTEMMar 11, 2011

Cardiovascular Systems Inc and the FDA: common questions

Has Cardiovascular Systems Inc received an FDA warning letter?

No FDA warning letter addressed to the name "Cardiovascular Systems Inc" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Cardiovascular Systems Inc received an FDA Form 483?

FDA has not published a Form 483 for "Cardiovascular Systems Inc" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Cardiovascular Systems Inc?

The most recent FDA inspection on file ended Dec 14, 2022 at Saint Paul, MN and was classified NAI. FDA has 9 inspections of Cardiovascular Systems Inc on file.

Has Cardiovascular Systems Inc had an FDA recall?

Yes. Cardiovascular Systems Inc has 15 FDA recalls on record, 3 of them Class I, the most serious class. The most recent under this name started Nov 22, 2021. A newer recall, dated Nov 13, 2025, is filed under the related name Abbott Laboratories.

Need more than this page shows? Ask about Cardiovascular Systems Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.